Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease
作者： Yoshiki Nishizawa , Tetsuo Shoji , Ryusuke Kakiya , Yoshihiro Tsujimoto , Tsutomu Tabata
DOI: 10.1046/J.1523-1755.63.S84.30.X
关键词:
摘要: Non-high-density lipoprotein cholesterol (non-HDL-C) as a terol (HDL-C) and increased plasma triglycerides due to predictor of cardiovascular mortality in patients with end-stage accumulation triglyceride-rich lipoproteins including renal disease. very-low-density (VLDL) intermediate-density lipo- Background. Patients disease (ESRD) proteins (IDL). Official recommendations the general often show lipid abnormalities that may promote atherosclero-
kidney-international.org
core.ac.uk
nature.com
elsevier.com
sci-hub.se 参考文章(10)
David Wood, Guy De Backer, Ole Faergeman, Ian Graham, Giuseppe Mancia, Kalevi Pyörälä, Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis. ,vol. 140, pp. 199- 270 ,(1998) , 10.1016/S0021-9150(98)90209-X
Tetsuo Shoji, Takahiko Kawagishi, Masanori Emoto, Kiyoshi Maekawa, Hiromichi Taniwaki, Hiroyuki Kanda, Yoshiki Nishizawa, Tsutomu Tabata, Additive impacts of diabetes and renal failure on carotid atherosclerosis Atherosclerosis. ,vol. 153, pp. 257- 258 ,(2000) , 10.1016/S0021-9150(00)00529-3
Philip H Frost, Richard J Havel, Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and Therapy American Journal of Cardiology. ,vol. 81, pp. 26- ,(1998) , 10.1016/S0002-9149(98)00034-4
Lora B. Wilder, Paul S. Bachorik, Cheryl A. Finney, Taryn F. Moy, Diane M. Becker, The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol The American Journal of Medicine. ,vol. 99, pp. 374- 377 ,(1995) , 10.1016/S0002-9343(99)80184-3
LIONEL U. MAILLOUX, BARBARA NAPOUTANO, ALESSANDRO C. BELLUCCI, ROBERT T. MOSSEY, MELCHIORE A. VERNACE, BARRY M. WILKES, The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients. Asaio Journal. ,vol. 42, pp. 164- 169 ,(1996) , 10.1097/00002480-199605000-00008
Takahiko Kawagishi, Yoshiki Nishizawa, Toshiaki Konishi, Koichi Kawasaki, Masanori Emoto, Tetsuo Shoji, Tsutomu Tabata, Takashi Inoue, Hirotoshi Morii, High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia Kidney International. ,vol. 48, pp. 820- 826 ,(1995) , 10.1038/KI.1995.356
E Trenkwalder, B Grabensee, F Kronenberg, D Bach, H Dieplinger, M Koch, B Kutkuhn, Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. Journal of The American Society of Nephrology. ,vol. 8, pp. 1889- 1898 ,(1997) , 10.1681/ASN.V8121889
Scott M. Grundy, Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA: The Journal of the American Medical Association. ,vol. 269, pp. 3015- 2497 ,(1993) , 10.1001/JAMA.1993.03500230097036
Ryusuke Kakiya, Eiji Ishimura, Yoshiki Nishizawa, Tsutomu Tabata, Kayo Shinohara, Masanori Emoto, Hiroshi Kishimoto, Tetsuo Shoji, Yoshihiro Tsujimoto, Diabetes Mellitus, Aortic Stiffness, and Cardiovascular Mortality in End-Stage Renal Disease Journal of The American Society of Nephrology. ,vol. 12, pp. 2117- 2124 ,(2001) , 10.1681/ASN.V12102117
Hiromichi Taniwaki, Hirotoshi Morii, Yoshiki Nishizawa, Takahiko Kawagishi, Tsutomu Tabata, Takashi Inoue, Koichi Kawasaki, Tetsuo Shoji, Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients Journal of The American Society of Nephrology. ,vol. 9, pp. 1277- 1284 ,(1998) , 10.1681/ASN.V971277